Answer
No. It is a monoclonal antibody targeting interleukin-5 and is used as add-on treatment rather than automatically replacing established asthma medicines.
Sources for this answer
- Cinqaero (reslizumab) 10 mg/mL concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.